Correction: Cannabis-based extract for managing pain in dogs with osteoarthritis: efficacy and safety assessment
Year: 2026
Type: erratum
Abstract: Correction on: Griebeler NM, Cremonese RP, Fakih Correa YR, Pereira PRM, Rial AF, Leite E, Gonçalves MVL, Marques das Almas LR, Cardoso NB, Cezar-dos-Santos F, Toci AT, Mojoli Le-Quesne A and Nascimento FP (2025) Cannabis-based extract for managing pain in dogs with osteoarthritis: efficacy and safety assessment. Front. Pharmacol. 16:1539704. doi: 10.3389/fphar.2025.1539704 The figure captions were in the wrong order in the PDF/HTML version of this paper. Figure 1 had the caption of Figure 2 "Biochemical marker levels during the 90-day treatment period. Part I. * p < 0.05 for significant differences between cannabis oil and placebo groups. (A) p < 0.05 for significant differences between time points 0 and 30 within the placebo group. (B) p < 0.05 for significant differences between time points 0 and 30 within the cannabis oil group. (C) p < 0.05 for significant differences between time points 0 and 90 within the cannabis oil group. (D) p < 0.05 for significant differences between time points 30 and 90 within the cannabis oil group. (E) p < 0.05 for significant differences between time points 30 and 90 within the placebo group."There was also a mistake in the caption of Figure 6 as published. Figure 6 "Biochemical marker levels during the 90-day treatment period. Part II.*p < 0.05 for significant differences between cannabis oil and placebo groups. (A) p < 0.05 for significant differences between time points 0 and 30 with in the placebo group. (B) p < 0.05 for significant differences between time points 0 and 30 with in the cannabis oil group. (C) p < 0.05 for significant differences between time points 0 and 90 with in the cannabis oil group. (D) p < 0.05 for Q27 significant differences between time points 30 and 90 with in the cannabis oilgroup. (E) p < 0.05 for significant differences between time points 30 and 90 with in the placebo group."The original version of this article has been updated. (A) p < 0.05 for significant differences between time points 0 and 30 within the placebo group. (B) p < 0.05 for significant differences between time points 0 and 30 within the cannabis oil group. (C) p < 0.05 for significant differences between time points 0 and 90 within the cannabis oil group. (D) p < 0.05 for significant differences between time points 30 and 90 within the cannabis oil group.(E) p < 0.05 for significant differences between time points 30 and 90 within the placebo group.Figure 6 Biochemical marker levels during the 90-day treatment period. Part II.*p < 0.05 for significant differences between cannabis oil and placebo groups. (A) p < 0.05 for significant differences between time points 0 and 30 with in the placebo group. (B) p < 0.05 for significant differences between time points 0 and 30 with in the cannabis oil group. (C) p < 0.05 for significant differences between time points 0 and 90 with in the cannabis oil group. (D) p < 0.05 for Q27 significant differences between time points 30 and 90 with in the cannabis oilgroup. (E) p < 0.05 for significant differences between time points 30 and 90 with in the placebo group.
Source: Frontiers in Pharmacology
Authors: Neide Maria Griebeler, Ricardo Penayo Cremonese, Yasmin Rafaela Fakih Correa, Priscila Romero Mazzini Pereira, Amanda Furjan Rial, Emanuela Leite, Maria Victoria Luz Gonçalves, Luiz Renato Marques das Almas, Nedice Borges Cardoso, Fernando Cezar-dos-Santos, Aline Theodoro Toci, Andrés Mojoli Le-Quesne, Francisney Pinto Nascimento
Institution: Universidade Federal da Integração Latino-Americana
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7124864094
Cites:
Cited by:
Related to: